Vaccine Hesitancy | Public Health and CDC/FDA Updates | March 8, 2021
Date of Presentation: March 8, 2021
Type: Past Presentation
Audience: Clinical
Program: Virology
Keywords: #covid clinical updates #vaccine hesitancy
In this series of presentations, Dr. Thomas Becker, Medical Epidemiologist and ECHO faculty member, provides a summary and article review of COVID-19 vaccine hesitancy. Then, Eileen M. Dunne, PhD, ECHO faculty member and Epidemic Intelligence Service Officer for the Centers for Disease Control and Prevention at the Idaho Division of Public Health, provides a public health practice update and a number of valuable COVID-19 related resources produced by the CDC and FDA.
Recording:
Presented by:
Dr. Tom Becker, Dr. Eileen M. Dunne
Thomas Becker, MD, PhD, is a medical epidemiologist, and trained in internal medicine, anthropology, and public health; he began his career at the University of New Mexico before moving to the Northwest about 20 years ago. Since his arrival in Portland, Becker has worked with the Northwest Portland Area Indian Health Board and Oregon Health & Science University. He has published on a diverse range of American Indian health issues, including both infectious and chronic diseases. And with the Indian Health Board, he has been involved in etiologic studies, community prevention programs and education programs to improve career opportunities for people in tribes nationwide.
Eileen M. Dunne, PhD, is an Epidemic Intelligence Service Officer for the Centers for Disease Control and Prevention at the Idaho Division of Public Health, Bureau of Communicable Disease Prevention.
Resources Provided:
- Vaccine Hesitancy (Presentation Slides)
- Public Health Updates (Presentation Slides)
- COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates (MDPI)
- Vaccine hesitancy and reasons for refusing the COVID-19 vaccination among the U.S. public: a cross-sectional survey (medRxiv)
- Urban Indian Health Institute Covid-19 vaccination survey report, 2021 (UIHI)
- Vaccine Hesitancy: Where We Are and Where We Are Going (ScienceDirect)
- BinaxNOW™ COVID-19 Ag Card Product Expiry Update (Abbot)
- An increase in willingness to vaccinate against COVID-19 in the US between October 2020 and February 2021: longitudinal evidence from the Understanding America Study (medRxiv)
- FDA Allows More Flexible Storage, Transportation Conditions for Pfizer-BioNTechCOVID-19 Vaccine (FDA)
- FDA Issues Authorization for Quidel Quick Vue At-Home COVID-19 Test (FDA)
- FDA Issues Authorization for Cue Non-prescription At-home COVID-19 Test (FDA)
- EUA for bamlanivimaband etesevimab (FDA)
- Suspected Recurrent SARS-CoV-2 Infections Among Residents of a Skilled Nursing Facility During a Second COVID-19 Outbreak —Kentucky, July–November 2020 (MMWR)
- Reduction in COVID-19 Patients Requiring Mechanical Ventilation Following Implementation of a National COVID-19 Vaccination Program —Israel, December 2020–February 2021 (MMWR)
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine —United States, February 2021 (MMWR)
- First Identified Cases of SARS-CoV-2 Variant P.1 in the United States —Minnesota, January 2021 (MMWR)
- Body Mass Index and Risk for COVID-19–Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death —United States, March–December 2020 (MMWR)
- Interim Public Health Recommendations for Fully Vaccinated People (CDC)
Date added: March 8, 2021